By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

Two new injectable drugs offer hope to the obese, especially diabetics, and could set off a pharma race to cash in on the ...

Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes ...

Altimmune shares cratered nearly 60% on Thursday after its experimental obesity drug did not significantly improve liver ...

(Yicai) June 27 -- China's drug regulator is expected to approve the country's first domestically produced glucagon-like ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

(Yicai) June 23 -- The efficacy of a glucagon-like peptide-1 weight-loss agonist developed by Chinese pharmaceutical firm ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...